Transducer array layout optimization for the treatment of pancreatic cancer using Tumor Treating Fields (TTFields) in the phase 3 PANOVA-3 trial.

被引：1
|
作者：
Naveh, Ariel
Hershkovich, Hadas Sara
Kirson, Eilon David
Weinberg, Uri
Bomzon, Zeev
机构：
[1] Novocure Ltd, Haifa, Israel
[2] Novocure, Haifa, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15766
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15766
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment of pancreatic cancer cells with tumor treating fields (TTFields) and PARP inhibitors
    Ene, Hila
    Ben Meir, Kerem
    Martinez-Conde, Antonia
    Frechtel-Gerzi, Roni
    Gabay, Hila
    Gerasimova, Daria
    Engelman, Rotem
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (06)
  • [22] OPTIMIZING TRANSDUCER ARRAY CONFIGURATION FOR TREATING TUMORS IN THE INFRATENTORIAL AND SUPRATENTORIAL BRAIN USING TUMOR TREATING FIELDS (TTFIELDS)
    Levi, Shay
    Naveh, Ariel
    Bomzon, Ze'ev
    Kirson, Eilon D.
    Weinberg, Uri
    NEURO-ONCOLOGY, 2017, 19 : 89 - 89
  • [23] PANOVA-3: A phase III study of TTFields with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma (LAPC)
    Weinberg, Uri
    Farber, Ori
    Giladi, Moshe
    Bomzon, Zeev
    Lavy-Shahaf, Gitit
    Kirson, Eilon D.
    CANCER RESEARCH, 2018, 78 (13)
  • [24] Tumor Treating Fields (TTFields) together with PARP inhibitors for treatment of pancreatic cancer cells
    Martinez-Conde, Antonia
    Ene, Hila
    Ben-Meir, Kerem
    Dor-On, Eyal
    Lamichhane, Puru
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (02)
  • [25] Drug loaded nanoparticle targeting of pancreatic cancer using tumor treating fields (TTFields).
    Desai, Preshita Prafulla
    Prabhu, Sunil
    CANCER RESEARCH, 2021, 81 (13)
  • [26] Tumor treating fields (TTFields) targeted self assembling nanoparticles for pancreatic cancer treatment: In vitro and in vivo assessment
    Desai, Preshita Prafulla
    Prabhu, Sunil
    CANCER RESEARCH, 2024, 84 (06)
  • [27] PI3K inhibition sensitize cancer cells to tumor treating fields (TTFields)
    Klein-Goldberg, Anat
    Voloshin, Tali
    Zemer-Tov, Efrat
    Paz, Rom
    Koren, Lilach
    Wainer-Katsir, Kerem
    Volodin, Alexandra
    Koltun, Bella
    Brant, Boris
    Barsheshet, Yiftah
    Kan, Tal
    David, Cfir
    Khalil, Tharwat Haj
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2023, 83 (07)
  • [28] Inhibition of PI3-Kinase sensitizes cancer cells to Tumor Treating Fields (TTFields)
    Klein-Goldberg, Anat
    Seitz, Stefanie
    Antonietti, Patrick
    Voloshin, Tali
    Zemer-Tov, Efrat
    Paz, Rom
    Koren, Lilach
    Wainer-Katsir, Kerem
    Volodin, Alexandra
    Koltun, Bella
    Brant, Boris
    Barsheshet, Yiftah
    Kan, Tal
    David, Cfir
    Khalil, Tharwat Haj
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S161 - S161
  • [29] SENSITIZING CANCER CELLS TO TUMOR TREATING FIELDS (TTFIELDS) BY INHIBITION OF PI3K
    Klein-Goldberg, Anat
    Voloshin, Tali
    Zemer-Tov, Efrat
    Paz, Rom
    Koren, Lilach
    Wainer-Katsir, Kerem
    Volodin, Alexandra
    Koltun, Bella
    Brant, Boris
    Barsheshet, Yiftah
    Kan, Tal
    Cohen, Gadi
    David, Cfir
    Khalil, Tharwat Haj
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2022, 24 : 48 - 48
  • [30] Inhibition of PI3K sensitized cancer cells to Tumor Treating Fields (TTFields)
    Klein-Goldberg, Anat
    Voloshin, Tali
    Zemer-Tov, Efrat
    Paz, Rom
    Koren, Lilach
    Wainer-Katsir, Kerem
    Volodin, Alexandra
    Koltun, Bella
    Brant, Boris
    Barsheshet, Yiftah
    Kan, Tal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2022, 82 (12)
12345